Long‐term effectiveness of enzyme replacement therapy in children with Gaucher disease: results from the NCS‐LSD cohort study. Issue 6 (18th March 2014)

• Record Type: Journal Article
• Authors: Anderson, L. J.; Henley, W.; Wyatt, K. M.; Nikolaou, V.; Waldek, S.; Hughes, D. A.; Pastores, G. M.; Logan, S.
• Is Part Of: Journal of inherited metabolic disease. Volume 37:Issue 6(2014)
• Page Start: 961
• Page End: 968
• Publication Date: 2014-03-18
• Subjects: Metabolism, Inborn errors of -- Periodicals; Metabolism -- Disorders -- Periodicals; 616.39042
• DOI: 10.1007/s10545-014-9693-8
• Languages: English
• ISSNs: 0141-8955

Abstract

Abstract: Objectives: To determine the effectiveness of enzyme replacement therapies (ERT) for children with Gaucher disease (GD). Design: A longitudinal cohort study including prospective and retrospective clinical data. Age‐ and gender‐adjusted treatment effects were estimated using generalised linear mixed models. Children on treatment contributed data before and during treatment. Children not on treatment contributed natural history data. Participants: Consenting children (N = 25, aged 1.1 to 15.6 years) with a diagnosis of GD (14 with GD1 and 11 with GD3) who attended a specialist treatment centre in England. At recruitment, 24 patients were receiving ERT (mean treatment duration, 5.57 years; range 0‐13.7 years). Outcome measures: Clinical outcomes chosen to reflect disease progression, included platelet count; haemoglobin and absence/presence of bone pain. Results: Duration of ERT was associated with statistically significant improvements in platelet count ( p < 0.001), haemoglobin ( p < 0.001), and reported bone pain ( p = 0.02). The magnitude of effect on haematological parameters was greater in children with GD3 than in those with GD1. Conclusions: These data provide further evidence of the long‐term effectiveness of ERT in children with GD.